A carregar...

Pioglitazone and sulfonylureas: effectively treating type 2 diabetes

Type 2 diabetes is characterised by a gradual decline in glycaemic control and progression from oral glucose-lowering monotherapy to combination therapy and exogenous insulin therapy. Functional decline of the insulin-secreting β-cells is largely responsible for the deterioration in glycaemic contro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Hanefeld, M
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1974826/
https://ncbi.nlm.nih.gov/pubmed/17594390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1742-1241.2007.01361.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!